Tumorigenic colon cancer cells cultured from a 72 year old Caucasian male patient with colorectal adenocarcinoma were used to develop the Caco-2 HTB-37 cell line. The Caco-2 cells are known to double in about 62 hours and have been characterized as tumorigenic, epithelial cells.The use of these cells as transfection models for human colon cancer research is faciliated by the use of Caco-2 transfection reagents created by Altogen Biosystems. The Caco-2 transfection reagent is a biodegradable polymer based reagent that yields high transfection efficacy while also being gentle enough to be used to analyze an individual cell.
Caco-2 Transfection Reagent (Colon Carcinoma Cells)
Caco-2 Transfection Reagent (Colon Carcinoma Cells)